Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mark N. Shahan"'
Autor:
Betsy L. Lytle, Brian F. Volkman, Francis C. Peterson, Dmitriy A. Vinarov, John L. Markley, Ejan M. Tyler, Sujatha Sampath, Mark N. Shahan
Publikováno v:
Protein Science. 14:2195-2200
Present in virtually every species, thioredoxins catalyze disulfide/dithiol exchange with various substrate proteins. While the human genome contains a single thioredoxin gene, plant thioredoxins are a complex protein family. A total of 19 different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a78d8f5a9dde07b723f161e5075f87e0
https://doi.org/10.1110/ps.051477905
https://doi.org/10.1110/ps.051477905
Autor:
John L. Markley, Ejan M. Tyler, Jikui Song, Mark N. Shahan, Robert C. Tyler, Dmitriy A. Vinarov
Publikováno v:
Journal of Biomolecular NMR. 30:215-218
Progesterone is believed to exert rapid non-genomic actions through its interaction with membrane associated progesterone receptors (MAPRs) (Bramley, 2003; Li and O’Malley, 2003). BLAST sequence searches (Altieri et al., 1995) for mammalian MAPRs a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2c8d1bf6e7692483399bd430b562267
https://doi.org/10.1023/b:jnmr.0000048943.34504.29
https://doi.org/10.1023/b:jnmr.0000048943.34504.29
Publikováno v:
Current Protocols in Protein Science
The Center for Eukaryotic Structural Genomics, in cooperation with Ehime University and CellFree Sciences, has developed a novel wheat germ cell-free technology for the production of eukaryotic proteins. Protein production and purification are robust
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f0f8c0e817cce187d36430e891b2173
https://pubmed.ncbi.nlm.nih.gov/18429309
https://pubmed.ncbi.nlm.nih.gov/18429309
Autor:
Craig A. Bingman, David J. Aceti, Robert C. Tyler, Qin Zhao, Ronnie O. Frederick, Dmitriy A. Vinarov, Jikui Song, Ejan M. Tyler, Francis C. Peterson, Claudia C. Cornilescu, Frank C. Vojtik, Mark N. Shahan, Russell L. Wrobel, Eldon L. Ulrich, Min S. Lee, George N. Phillips, Brian F. Volkman, Won Bae Jeon, Brian G. Fox, John L. Markley, Craig S. Newman, Hassan K. Sreenath, Shanteri Singh
Publikováno v:
Proteins. 59(3)
We describe a comparative study of protein production from 96 Arabidopsis thaliana open reading frames (ORFs) by cell-based and cell-free protocols. Each target was carried through four pipeline protocols used by the Center for Eukaryotic Structural
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1c227406df12048c87075e7ce6ee11a
https://pubmed.ncbi.nlm.nih.gov/15789406
https://pubmed.ncbi.nlm.nih.gov/15789406
Autor:
Jikui, Song, Dmitriy, Vinarov, Ejan M, Tyler, Mark N, Shahan, Robert C, Tyler, John L, Markley
Publikováno v:
Journal of biomolecular NMR. 30(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::42c8977ad8fcb5a2912b97fc893f372a
https://pubmed.ncbi.nlm.nih.gov/15702529
https://pubmed.ncbi.nlm.nih.gov/15702529
Publikováno v:
Cancer Research. 73:4405-4405
Ribonucleases (RNases) are a unique class of anti-cancer drugs that target the RNA in cancer cells without the complications of delivering RNA. Efficacious RNases have diminished binding to the naturally occurring RNase inhibitor protein in the cytos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcc40c40c496e9da5c4a3037abaf5c33
https://doi.org/10.1158/1538-7445.am2013-4405
https://doi.org/10.1158/1538-7445.am2013-4405
Publikováno v:
Journal of Clinical Oncology. 30:TPS3113-TPS3113
TPS3113 Background: RNA has been recognized as a drug target for cancer therapy, as evidenced by the ongoing clinical trials of RNAi and antisense therapies. An alternative approach that circumvents the delivery and stability issues of RNAi and antis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8692e1bea2aa838b4422608ce4226e55
https://doi.org/10.1200/jco.2012.30.15_suppl.tps3113
https://doi.org/10.1200/jco.2012.30.15_suppl.tps3113
Autor:
Laura E. Strong, John A. Kink, Ronald T. Raines, Baigen Mei, Mark N. Shahan, Daniel Pensinger
Publikováno v:
Cancer Research. 72:1838-1838
RNA has been recognized as a drug target for cancer therapy, as evidenced by the ongoing clinical trials of RNAi and antisense therapies. An alternative approach that circumvents the delivery and stability issues of those drugs is to harness the acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4bd93402994a4efd8586c1630612af8
https://doi.org/10.1158/1538-7445.am2012-1838
https://doi.org/10.1158/1538-7445.am2012-1838
Publikováno v:
Journal of Clinical Oncology. 29:TPS146-TPS146
TPS146 Background: RNA has been recognized as a drug target for cancer therapy, as evidenced by the ongoing clinical trials of RNAi and antisense therapies. An alternative approach that circumvents the delivery and stability issues of RNAi and antise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdfc95195a8937cd5f144261286cb528
https://doi.org/10.1200/jco.2011.29.15_suppl.tps146
https://doi.org/10.1200/jco.2011.29.15_suppl.tps146
Autor:
Baigen Mei, John A. Kink, Laura E. Strong, Mark N. Shahan, Ronald T. Raines, Daniel Pensinger
Publikováno v:
Cancer Research. 71:2573-2573
RNA has been recognized as a drug target for cancer therapy, as evidenced by the ongoing clinical trials of RNAi and antisense therapies. An alternative approach that circumvents the delivery and stability issues of RNAi and antisense is to harness t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d0ddd992ad08b4e714a934dcd2c8521
https://doi.org/10.1158/1538-7445.am2011-2573
https://doi.org/10.1158/1538-7445.am2011-2573